50% Off! Beat the market in 2025 with InvestingProCLAIM SALE

Morgan Stanley B.V. announces partial cancellation of securities

Published 12/10/2024, 09:26 AM

LONDON - Morgan Stanley (NYSE:MS) B.V. has initiated a partial cancellation of several securities, as per a notice dated December 10, 2024. The cancellation affects a variety of securities with different International Securities Identification Numbers (ISINs) and Committee on Uniform Securities Identification Procedures (CUSIPs).

The securities subject to partial cancellation, along with their respective unwind amounts and new outstanding amounts, are detailed as follows: ISIN XS2877165758 with an unwind amount of $100,000 and a new outstanding amount of $350,000; ISIN XS2817723500 with $200,000 unwound leaving $2,700,000; ISIN XS2846449051 with $136,000 unwound leaving $1,400,000; ISIN XS2424563869 with $70,000 unwound leaving $390,000; ISIN XS2326200487 with $25,000 unwound leaving $4,056,000; ISIN XS2846394059 with $250,000 unwound leaving $250,000; ISIN XS2862240160 with $150,000 unwound leaving $50,000; and ISIN XS2877221171 with $100,000 unwound leaving $100,000.

The settlement date for the partial cancellations is December 12, 2024. Following the cancellation, the outstanding issuance amount for each security will be adjusted to reflect the reduced quantities.

Morgan Stanley B.V. has not provided specific reasons for the partial cancellation of these securities. The notice encourages any parties with questions or in need of further information to make direct contact.

This action by Morgan Stanley B.V. is a routine financial operation that involves adjusting the available amount of certain securities in the market. Such adjustments can be part of regular financial management practices, including debt restructuring or managing the supply of securities in the market.

The information regarding this partial cancellation is based on a press release statement and has been disseminated through RNS, the news service of the London Stock Exchange (LON:LSEG). RNS is authorized by the Financial Conduct Authority in the UK to act as a Primary Information Provider.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.